AKT1 and cervical cancer: Furthermore, triciribine, targeting and reducing signaling in the ZNF275-induced AKT pathway, exhibited a tumor-suppressive role and sensitized cisplatin chemotherapy efficacy in cervical cancer cells expressing high ZNF275.